These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 30149603)

  • 1. Recombinant Fusion Protein Joining E Protein Domain III of Tick-Borne Encephalitis Virus and HSP70 of
    Golotin V; Sanina N; Davydova L; Chopenko N; Mazeika A; Roig M; Shnyrov V; Uversky VN; Kostetsky E
    Biomolecules; 2018 Aug; 8(3):. PubMed ID: 30149603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity and Protective Activity of a Chimeric Protein Based on the Domain III of the Tick-Borne Encephalitis Virus E Protein and the OmpF Porin of
    Sanina N; Chopenko N; Mazeika A; Davydova L; Leonova G; Stenkova A; Uversky VN; Kostetsky E
    Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30274357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineering of Chimeric Protein Based on E Protein Domain III of Tick- Borne Encephalitis Virus and OmpF Porin of Yersinia pseudotuberculosis.
    Stenkova AM; Chopenko NS; Davydova LA; Mazeika AN; Bystritskaya EP; Portnyagina OY; Anastyuk SD; Kulbatskii DS; Lyukmanova EN; Dolgikh DA; Kostetsky EY; Sanina NM
    Protein Pept Lett; 2017; 24(10):974-981. PubMed ID: 28741465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant domains III of Tick-Borne Encephalitis Virus envelope protein in combination with dextran and CpGs induce immune response and partial protectiveness against TBE virus infection in mice.
    Ershova AS; Gra OA; Lyaschuk AM; Grunina TM; Tkachuk AP; Bartov MS; Savina DM; Sergienko OV; Galushkina ZM; Gudov VP; Kozlovskaya LI; Kholodilov IS; Gmyl LV; Karganova GG; Lunin VG; Karyagina AS; Gintsburg AL
    BMC Infect Dis; 2016 Oct; 16(1):544. PubMed ID: 27717318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Basis of a Protective/Neutralizing Monoclonal Antibody Targeting Envelope Proteins of both Tick-Borne Encephalitis Virus and Louping Ill Virus.
    Yang X; Qi J; Peng R; Dai L; Gould EA; Gao GF; Tien P
    J Virol; 2019 Apr; 93(8):. PubMed ID: 30760569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Japanese encephalitis protein vaccine candidates expressing neutralizing epitope and M.T hsp70 induce virus-specific memory B cells and long-lasting antibodies in swine.
    Fei-fei G; Jian W; Feng X; Li-ping S; Quan-yun S; Jin-ping Z; Pu-yan C; Pei-hong L
    Vaccine; 2008 Oct; 26(44):5590-4. PubMed ID: 18761388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccine Potential of a Recombinant Bivalent Fusion Protein LcrV-HSP70 Against Plague and Yersiniosis.
    Gupta A; Narayan B; Kumar S; Verma SK
    Front Immunol; 2020; 11():988. PubMed ID: 32595634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the Langat/dengue 4 chimeric virus as a live attenuated tick-borne encephalitis vaccine for safety and immunogenicity in healthy adult volunteers.
    Wright PF; Ankrah S; Henderson SE; Durbin AP; Speicher J; Whitehead SS; Murphy BR; Pletnev AG
    Vaccine; 2008 Feb; 26(7):882-90. PubMed ID: 18207289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stable and Highly Immunogenic MicroRNA-Targeted Single-Dose Live Attenuated Vaccine Candidate against Tick-Borne Encephalitis Constructed Using Genetic Backbone of Langat Virus.
    Tsetsarkin KA; Maximova OA; Liu G; Kenney H; Teterina NL; Pletnev AG
    mBio; 2019 Apr; 10(2):. PubMed ID: 31015334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A method for rapid and high-yield production of the tick-borne encephalitis virus E and DIII recombinant proteins in E. coli with preservation of the antigenic properties.
    Rizzo S; Mora-Cárdenas E; Faoro V; D'Agaro P; Edomi P; Marcello A; Sblattero D
    Ticks Tick Borne Dis; 2019 Jun; 10(4):935-941. PubMed ID: 31072731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recovery of West Nile Virus Envelope Protein Domain III Chimeras with Altered Antigenicity and Mouse Virulence.
    McAuley AJ; Torres M; Plante JA; Huang CY; Bente DA; Beasley DWC
    J Virol; 2016 May; 90(9):4757-4770. PubMed ID: 26912625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tick-borne Langat/mosquito-borne dengue flavivirus chimera, a candidate live attenuated vaccine for protection against disease caused by members of the tick-borne encephalitis virus complex: evaluation in rhesus monkeys and in mosquitoes.
    Pletnev AG; Bray M; Hanley KA; Speicher J; Elkins R
    J Virol; 2001 Sep; 75(17):8259-67. PubMed ID: 11483771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The envelope protein of tick-borne encephalitis virus influences neuron entry, pathogenicity, and vaccine protection.
    Lindqvist R; Rosendal E; Weber E; Asghar N; Schreier S; Lenman A; Johansson M; Dobler G; Bestehorn M; Kröger A; Överby AK
    J Neuroinflammation; 2020 Sep; 17(1):284. PubMed ID: 32988388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction and characterization of chimeric tick-borne encephalitis/dengue type 4 viruses.
    Pletnev AG; Bray M; Huggins J; Lai CJ
    Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10532-6. PubMed ID: 1438242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Basis of the Divergent Immunogenicity of Two Pediatric Tick-Borne Encephalitis Virus Vaccines.
    Beck Y; Fritz R; Orlinger K; Kiermayr S; Ilk R; Portsmouth D; Pöllabauer EM; Löw-Baselli A; Hessel A; Kölch D; Howard MK; Barrett PN; Kreil TR
    J Virol; 2016 Feb; 90(4):1964-72. PubMed ID: 26656681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant chimeric Japanese encephalitis virus/tick-borne encephalitis virus is attenuated and protective in mice.
    Wang HJ; Li XF; Ye Q; Li SH; Deng YQ; Zhao H; Xu YP; Ma J; Qin ED; Qin CF
    Vaccine; 2014 Feb; 32(8):949-56. PubMed ID: 24394443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insertion of microRNA targets into the flavivirus genome alters its highly neurovirulent phenotype.
    Heiss BL; Maximova OA; Pletnev AG
    J Virol; 2011 Feb; 85(4):1464-72. PubMed ID: 21123372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of chimeric DNA vaccines consisting of premembrane and envelope genes of Japanese encephalitis and dengue viruses as a strategy for reducing induction of dengue virus infection-enhancing antibody response.
    Sjatha F; Kuwahara M; Sudiro TM; Kameoka M; Konishi E
    Microbiol Immunol; 2014 Feb; 58(2):126-34. PubMed ID: 24372832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiviral activity of porphyrins and porphyrin-like compounds against tick-borne encephalitis virus: Blockage of the viral entry/fusion machinery by photosensitization-mediated destruction of the viral envelope.
    Holoubek J; Salát J; Kotouček J; Kastl T; Vancová M; Huvarová I; Bednář P; Bednářová K; Růžek D; Renčiuk D; Eyer L
    Antiviral Res; 2024 Jan; 221():105767. PubMed ID: 38040199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity against Far Eastern and Siberian subtypes of tick-borne encephalitis (TBE) virus elicited by the currently available vaccines based on the European subtype: systematic review and meta-analysis.
    Domnich A; Panatto D; Arbuzova EK; Signori A; Avio U; Gasparini R; Amicizia D
    Hum Vaccin Immunother; 2014; 10(10):2819-33. PubMed ID: 25483679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.